BIRK

Birkenstock Holding Plc - Form 6-K Summary

Business Context and Reporting Period

This Form 6-K reports the unaudited interim condensed consolidated financial results for Birkenstock Holding Plc for the three and nine months ended June 30, 2024. The Company is a global manufacturer and seller of footbed-based products, operating through three reportable segments: Americas, Europe, and APMA (Asia Pacific, Middle East, Africa). The fiscal year ends on September 30.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Revenue increased 19% year-over-year (YoY) for the three months and 21% YoY for the nine months ended June 30, 2024. Growth was driven by unit volume and average selling price (ASP) increases across all segments.
• Segment Performance: The APMA segment showed the strongest growth at 36% (3 months) and 40% (9 months). Americas grew 16% and Europe 20% for the three-month period.
• Margin Contraction: Gross profit margin decreased by 220 basis points to 59.5% (3 months) and 58.7% (9 months) compared to the prior year. This was primarily due to temporary under-absorption of costs from production capacity expansion and a higher mix of B2B sales (which have lower margins than DTC).
• Profitability: Net profit increased 18% YoY for the three months and 35% YoY for the nine months. Adjusted EBITDA grew 15% (3 months) and 11% (9 months).
• Debt Reduction: Total loans and borrowings decreased significantly from €1.85 billion (Sep 30, 2023) to €1.34 billion (June 30, 2024) following early repayments of €100 million on the Vendor Loan and $450 million on the USD Term Loan Facility using IPO proceeds.

Guidance, Outlook, and Risks

• Refinancing: On May 28, 2024, the Company entered into a new syndicated credit facility (effective August 2, 2024) replacing existing term loans. This includes a €375 million Euro term loan, a $280 million USD term loan, and a €225 million revolving facility. The new terms represent a significant reduction in interest expense.
• Secondary Offering: A secondary offering of 14 million shares by the controlling shareholder (MidCo) was completed on June 28, 2024, with an over-allotment option exercised on July 3, 2024. The Company did not receive proceeds from this offering.
• Tax Receivable Agreement (TRA): The Company has a liability of €353.6 million related to the TRA, with expected future payments totaling approximately $554.7 million over 13 years.
• Legal Proceedings: The Company is defending an appeal by a former French distributor. The plaintiff's claims in the appeal total approximately €41.6 million. The Company has recognized a provision for its best estimate of probable cash outflow.
• Seasonality: The business remains subject to seasonality, with B2B revenue peaking in spring and DTC revenue increasing in summer. Unseasonable weather could impact results.

Investor Verification Checklist

• Capacity Expansion Impact: Verify the timeline for the completion of production capacity expansion in Germany and Portugal to assess when gross margin compression may reverse.
• Debt Service Costs: Confirm the effective interest rate and amortization schedule of the new credit facility signed in May 2024 to validate future finance cost projections.
• TRA Liability Sensitivity: Review the assumptions regarding future taxable income used to calculate the €353.6 million Tax Receivable Agreement liability.
• Legal Contingency: Monitor the status of the French distributor appeal and the adequacy of the current provision against the €41.6 million claim.
• DTC vs. B2B Mix: Track the shift in revenue mix between Direct-to-Consumer (DTC) and Business-to-Business (B2B) channels, as this significantly impacts gross margins.